Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Papaverine (Intra-arterial)
Treatment for Vascular intestinal disorders
Typical Dosage: 30-60 mg/hr intra-arterially
Effectiveness
85%
Safety Score
50%
Clinical Trials
30
Participants
300
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
30-60 mg/hr intra-arterially
Time to Effect
Minutes-hours
Treatment Duration
24-72 hours
Evidence Quality
LOWConfidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$8,000
Side Effect Mgmt:$500
Total Annual:$8,600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$11,467
Comparison vs Supportive Care Only (for NOMI)
Cost Difference
$-50,000/year
Less expensive
QALY Difference
+1.00 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Papaverine (Intra-arterial) Outcomes
for Vascular intestinal disorders
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+75%
Common Side Effects
Hypotension
+5%
Cardiac arrhythmias
+2%
Local arterial complications
+3%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov